NCT06962813

Brief Summary

This study tested V Eraser, Transdermal radiofrequency versus polidocanol sclerotherapy for the treatment of reticular veins and telangiectasia of the legs

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 2, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

April 30, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 8, 2025

Completed
Last Updated

May 8, 2025

Status Verified

April 1, 2025

Enrollment Period

2 years

First QC Date

April 30, 2025

Last Update Submit

May 7, 2025

Conditions

Keywords

radiofrequencysclerotherapyvaricose veins

Outcome Measures

Primary Outcomes (2)

  • Photographic analysis

    Image analysis of photos was performed on day 30. Using the ImageJ software, two blinded evaluators analyzed the pre- and post-procedure photographs, measuring the vessel lengths in both images

    30 days

  • Aberdeen AVVQ questionnaire

    The Aberdeen Varicose Vein Questionnaire (AVVQ) was applied on day 30

    30 days

Study Arms (2)

Radiofrequency V Eraser

EXPERIMENTAL

radiofrequency

Procedure: Radiofrequency V Eraser

Polidocanol sclerotherapy

ACTIVE COMPARATOR

Standard of care, varicose veins, sclerotherapy

Procedure: Radiofrequency V Eraser

Interventions

standar of care sclerotherapy

Polidocanol sclerotherapyRadiofrequency V Eraser

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients willing to sign informed consent
  • Patients from 18 to 80 years old with CVD classified as CEAP clinical classes C1 to C5, but only telangiectasias and reticular veins not connected to larger varicosities

You may not qualify if:

  • Patients with great saphenous or small saphenous vein insufficiency.
  • Patients with allergies to polidocanol
  • Patients with contraindications to treat varicose veins

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital São Luiz Gonzaga and Hospital da Irmandade Santa Casa de Misericórdia de São Paulo

São Paulo, São Paulo, 02276-140, Brazil

Location

Related Publications (5)

  • Moreno-Moraga J, Pascu ML, Alcolea JM, Smarandache A, Royo J, David F, Trelles MA. Effects of 1064-nm Nd:YAG long-pulse laser on polidocanol microfoam injected for varicose vein treatment: a controlled observational study of 404 legs, after 5-year-long treatment. Lasers Med Sci. 2019 Sep;34(7):1325-1332. doi: 10.1007/s10103-019-02736-1. Epub 2019 Feb 1.

    PMID: 30707327BACKGROUND
  • Siribumrungwong B, Noorit P, Reanpang T, Pornwaragorn C, Wilasrusmee C, Wongsuwanich S, Srikuea K, Orrapin S, Benyakorn T, Garratt AM, Rerkaserm K. Reliability, validity, and minimal clinically important differences for the Thai-version of the Aberdeen Varicose Vein Questionnaire (AVVQ-Thai) in patients with chronic venous disease. F1000Res. 2024 Oct 11;13:486. doi: 10.12688/f1000research.147716.2. eCollection 2024.

    PMID: 39925999BACKGROUND
  • Diken AI, Alemdaroglu U, Ozyalcin S, Hafez I, Tunel HA, Yalcinkaya A, Ecevit AN. Adjuvant radiofrequency thermocoagulation improves the outcome of liquid sclerotherapy in the treatment of spider veins of the leg: A pilot study. Phlebology. 2021 Sep;36(8):620-626. doi: 10.1177/02683555211006534. Epub 2021 Apr 4.

    PMID: 33813962BACKGROUND
  • Key DJ. A Preliminary Study of a Transdermal Radiofrequency Device for Body Slimming. J Drugs Dermatol. 2015 Nov;14(11):1272-8.

    PMID: 26580877BACKGROUND
  • Gloviczki P, Lawrence PF, Wasan SM, Meissner MH, Almeida J, Brown KR, Bush RL, Di Iorio M, Fish J, Fukaya E, Gloviczki ML, Hingorani A, Jayaraj A, Kolluri R, Murad MH, Obi AT, Ozsvath KJ, Singh MJ, Vayuvegula S, Welch HJ. The 2022 Society for Vascular Surgery, American Venous Forum, and American Vein and Lymphatic Society clinical practice guidelines for the management of varicose veins of the lower extremities. Part I. Duplex Scanning and Treatment of Superficial Truncal Reflux: Endorsed by the Society for Vascular Medicine and the International Union of Phlebology. J Vasc Surg Venous Lymphat Disord. 2023 Mar;11(2):231-261.e6. doi: 10.1016/j.jvsv.2022.09.004. Epub 2022 Oct 12.

    PMID: 36326210BACKGROUND

MeSH Terms

Conditions

TelangiectasisVaricose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Rebeca Higino, MD

    Faculty of Medical Sciences of Santa Casa de São Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 arm parallel study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior investigator

Study Record Dates

First Submitted

April 30, 2025

First Posted

May 8, 2025

Study Start

January 10, 2023

Primary Completion

January 2, 2025

Study Completion

April 10, 2025

Last Updated

May 8, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations